Background illustration for clinical trials search

Obesity Clinical Trials

Browse 725 Obesity clinical trials enrolling across the United States and Canada. 983 people applied to Obesity studies last month. Search by city or state to find one near you.

Filter
1
Active & Responsive

A Research Study Looking Into How UBT251 Works With Birth Control Tablets and Emptying of the Stomach in Women With Excess Body Weight Not Able to Become Pregnant

for
Overweight, Obesity
Location: Montreal
Sponsor: Novo Nordisk A/S

Sex: Female

Age: 18 - 65

Code: NCT07710729

Phase 1, Recruiting
Active & Responsive

Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events

for
Obesity, Overweight
Location: Wilmington NC, Pembroke Pines FL, Weston FL, Monroe NC,
Sponsor: Novo Nordisk A/S

Sex: All

Age: 18+

Code: NCT07607587

Phase 1, Recruiting
Active & Responsive

A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight

for
Overweight, Obesity
Location: Newport News VA, Wilmington NC, Richmond VA,
Sponsor: Novo Nordisk A/S

Sex: All

Age: 18+

Code: NCT07745504

Phase 3, Recruiting
Active & Responsive

A Research Study Investigating How a New Medicine NNC0113-5840 Works in People With Overweight or Obesity

for
Obesity, Overweight
Location: Baltimore MD, Glendale CA
Sponsor: Novo Nordisk A/S

Sex: All

Age: 18 - 55

Code: NCT07566390

Phase 1, Recruiting
Active & Responsive

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

for
Overweight, Obesity
Location: Cumberland RI, New York NY, Newport News VA,
Sponsor: Novo Nordisk A/S

Sex: All

Age: 18+

Code: NCT07720271

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

for
Obesity, Overweight, Obstructive Sleep Apnoea
Location: New York NY, West Palm Beach FL, Columbia SC, Naples FL,
Sponsor: Novo Nordisk A/S

Sex: All

Age: 18+

Code: NCT07571109

Phase 3, Recruiting
Active & Responsive

Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight

for
Overweight, Obesity
Location: Winchester VA, Delray Beach FL, Fort Myers FL, Tampa FL,
Sponsor: Novo Nordisk A/S

Sex: All

Age: 18+

Code: NCT07770841

Phase 3, Recruiting
Active & Responsive

AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

for
Obesity, Overweight, Obstructive Sleep Apnoea
Location: New York NY, Miami FL, Atlanta GA, Ocala FL,
Sponsor: Novo Nordisk A/S

Sex: All

Age: 18+

Code: NCT07571005

Phase 3, Recruiting
Active & Responsive

A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or Obesity

for
Overweight, Obesity
Location: Montreal, Overland Park KS, Cypress CA
Sponsor: Novo Nordisk A/S

Sex: All

Age: 18 - 65

Code: NCT07395687

Phase 2, Recruiting
Active & Responsive

AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

for
Obesity, Overweight, Osteoarthritis, Knee
Location: Levis, Sherbrooke, Waterbury CT, Quebec, New York NY,
Sponsor: Novo Nordisk A/S

Sex: All

Age: 18+

Code: NCT07509307

Phase 3, Recruiting
Active & Responsive

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

for
Obesity, Heart Failure
Location: Moncton, Quebec, Sherbrooke, Chicoutimi, Brooklyn NY,
Sponsor: Novo Nordisk A/S

Sex: All

Age: 18+

Code: NCT07567001

Phase 3, Recruiting
Active & Responsive

A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

for
Obesity, Type 2 Diabetes
Location: Sydney, Halifax, Moncton, Quebec, Montreal,
Sponsor: Novo Nordisk A/S

Sex: All

Age: 18+

Code: NCT07564414

Phase 3, Recruiting
Active & Responsive

AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight

for
Obesity
Location: Halifax, Moncton, Cumberland RI, New York NY,
Sponsor: Novo Nordisk A/S

Sex: All

Age: 18+

Code: NCT07339423

Phase 3, Recruiting
Active & Responsive

A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

for
Obesity, Knee Osteoarthritis (OA)
Location: Waltham MA, Hamden CT, Quebec, Waterbury CT,
Sponsor: Novo Nordisk A/S

Sex: All

Age: 18+

Code: NCT07481630

Phase 3, Recruiting

Experience Success: Virtual Reality Skills Training to Enhance e-Weight Loss

for
Overweight, Obesity
Location: Providence RI
Sponsor: The Miriam Hospital

Sex: All

Age: 18 - 70

Code: NCT02836132

Recruiting

Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity

for
Obesity, Overweight and Obesity, Overweight
Location: Palo Alto CA
Sponsor: Stanford University

Sex: All

Age: 18 - 70

Code: NCT05912621

Phase 2, Recruiting

Energy Balancing Modeling and Mobile Technology to Support e-Weight Loss

for
Overweight, Obesity
Location: Providence RI
Sponsor: The Miriam Hospital

Sex: All

Age: 18 - 70

Code: NCT02857595

Recruiting

A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New Treatment (Zenagamtide) From Their Current Semaglutide Medication

for
Overweight, Obesity, Type 2 Diabetes
Location: Baltimore MD, Glendale CA
Sponsor: Novo Nordisk A/S

Sex: All

Age: 18+

Code: NCT07855133

Phase 1, Recruiting

A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New Treatment (Zenagamtide) From Their Current Tirzepatide Medication

for
Overweight, Obesity, Type 2 Diabetes
Location: Baltimore MD, Glendale CA
Sponsor: Novo Nordisk A/S

Sex: All

Age: 18+

Code: NCT07868354

Phase 1, Recruiting

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

for
Overweight, Obesity
Location: Washington D.C. DC, Syracuse NY, Danville PA,
Sponsor: Novo Nordisk A/S

Sex: All

Age: 18+

Code: NCT07668414

Phase 3, Recruiting

What is obesity?

Obesity is a chronic disease in which excess body fat harms health, usually defined by a body mass index of 30 or more, and it affects about 4 in 10 adults in the United States. It raises the risk of type 2 diabetes, high blood pressure, heart disease, sleep apnea, fatty liver disease, joint damage, and several cancers. Genetics, hormones that regulate hunger, sleep, medicines, and the food environment all contribute, which is why willpower alone rarely works and why obesity is treated as a medical condition rather than a personal failing.

Treatment combines nutrition and activity support with, for many people, medicines or surgery. The newest medicines, which act on gut hormones that control appetite, produce weight loss once possible only with surgery, and they are covered in detail on our weight loss treatment trials page. Trials here study every part of that picture, from new medicines and devices to behavioral programs and the conditions obesity causes.

Article preview image

Learn more in our article: Obesity and Clinical Trials: Weight Loss Research Explained.

Obesity and Clinical Trials: Advancing Safe Weight Loss Treatments

Types of obesity clinical trials

Who can participate in obesity clinical trials?

Do obesity trial participants get paid?

How long do obesity clinical trials typically last?

How to enroll in a clinical trial for obesity